TY  - GEN
AU  - Schühlen,Helmut
AU  - Abts,Markus
AU  - Kastrati,Dorejd
TI  - [Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study]
SN  - 0340-9937
PY  - 2007///1113
KW  - Antihypertensive Agents
KW  - administration & dosage
KW  - Death, Sudden, Cardiac
KW  - epidemiology
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Germany
KW  - Humans
KW  - Hydrochlorothiazide
KW  - Hypertension
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Risk Assessment
KW  - methods
KW  - Risk Factors
KW  - Tetrazoles
KW  - Treatment Outcome
KW  - Valine
KW  - Valsartan
N1  - Publication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s00059-007-2999-7
ER  -